BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33834151)

  • 1. Longitudinal Changes in Hematologic Parameters Among Transgender People Receiving Hormone Therapy.
    Antun A; Zhang Q; Bhasin S; Bradlyn A; Flanders WD; Getahun D; Lash TL; Nash R; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Endocr Soc; 2020 Nov; 4(11):bvaa119. PubMed ID: 33834151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between gender-affirming hormone therapy and measures of glucose metabolism: A longitudinal study.
    Anike O; Zhang Q; Bhasin S; Flanders WD; Getahun D; Haw JS; Huybrechts KF; Lash TL; McCracken CE; Roblin D; Silverberg MJ; Suglia SF; Tangpricha V; Vupputuri S; Goodman M
    J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38815002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There a Link Between Hormone Use and Diabetes Incidence in Transgender People? Data From the STRONG Cohort.
    Islam N; Nash R; Zhang Q; Panagiotakopoulos L; Daley T; Bhasin S; Getahun D; Sonya Haw J; McCracken C; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1549-e1557. PubMed ID: 34850912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence.
    Defreyne J; Elaut E; Kreukels B; Fisher AD; Castellini G; Staphorsius A; Den Heijer M; Heylens G; T'Sjoen G
    J Sex Med; 2020 Apr; 17(4):812-825. PubMed ID: 32008926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV burden and correlates of infection among transfeminine people and cisgender men who have sex with men in Nairobi, Kenya: an observational study.
    Smith AD; Kimani J; Kabuti R; Weatherburn P; Fearon E; Bourne A
    Lancet HIV; 2021 May; 8(5):e274-e283. PubMed ID: 33631101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Mortality Among Transgender and Gender Diverse Adults in England.
    Jackson SS; Brown J; Pfeiffer RM; Shrewsbury D; O'Callaghan S; Berner AM; Gadalla SM; Shiels MS
    JAMA Netw Open; 2023 Jan; 6(1):e2253687. PubMed ID: 36716027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Co-occurrence of Alcohol, Nicotine, and Other Substance Use Disorder Diagnoses Among US Transgender and Cisgender Adults.
    Hughto JMW; Quinn EK; Dunbar MS; Rose AJ; Shireman TI; Jasuja GK
    JAMA Netw Open; 2021 Feb; 4(2):e2036512. PubMed ID: 33538824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Psoriasis and Perceived Association with Hormone Therapy in Transgender Adults.
    Braun H; Thompson EC; Zhang Q; Tangpricha V; Goodman M; Yeung H
    Transgend Health; 2023 Aug; 8(4):396-399. PubMed ID: 37525834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
    Getahun D; Nash R; Flanders WD; Baird TC; Becerra-Culqui TA; Cromwell L; Hunkeler E; Lash TL; Millman A; Quinn VP; Robinson B; Roblin D; Silverberg MJ; Safer J; Slovis J; Tangpricha V; Goodman M
    Ann Intern Med; 2018 Aug; 169(4):205-213. PubMed ID: 29987313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study.
    Gao JL; Sanz J; Tan N; King DS; Modest AM; Dommasch ED
    J Am Acad Dermatol; 2023 Sep; 89(3):504-510. PubMed ID: 36780950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.
    Oakes M; Arastu A; Kato C; Somers J; Holly HD; Elstrott BK; Dy GW; Kohs TCL; Patel RR; McCarty OJT; DeLoughery TG; Milano C; Raghunathan V; Shatzel JJ
    Thromb Res; 2021 Nov; 207():96-98. PubMed ID: 34592628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematology reference intervals for transgender adults on stable hormone therapy.
    Greene DN; McPherson GW; Rongitsch J; Imborek KL; Schmidt RL; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
    Clin Chim Acta; 2019 May; 492():84-90. PubMed ID: 30771301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy.
    Humble RM; Greene DN; Schmidt RL; Winston McPherson G; Rongitsch J; Imborek KL; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
    J Appl Lab Med; 2022 Sep; 7(5):1131-1144. PubMed ID: 35584132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
    van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
    J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Satisfaction with current hormone therapy and goals of additional gender-affirming care in transgender adults.
    Siira M; Getahun D; Silverberg MJ; Tangpricha V; Goodman M; Yeung H
    J Sex Med; 2023 Mar; 20(4):568-572. PubMed ID: 36796861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocytosis in Gender-Affirming Care With Testosterone.
    Porat AT; Ellwood M; Rodina M; Dianat S
    Ann Fam Med; 2023; 21(5):403-407. PubMed ID: 37748907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference intervals for biochemical analytes in transgender individuals on hormone therapy.
    Bezuidenhout MC; Conradie-Smit M; Dave JA; de Vries E; Ross IL; Zemlin AE
    Ann Clin Biochem; 2022 May; 59(3):183-192. PubMed ID: 35044249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body Composition and Markers of Cardiometabolic Health in Transgender Youth Compared With Cisgender Youth.
    Nokoff NJ; Scarbro SL; Moreau KL; Zeitler P; Nadeau KJ; Juarez-Colunga E; Kelsey MM
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e704-14. PubMed ID: 31544944
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.